Discover 3,600 paid clinical trials in Glendale, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,600
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women
for
Coronary Artery Disease
Location: Glendale CA, Dallas TX, Memphis TN, Nashville TN,
Sponsor: Weill Medical College of Cornell University
Sex: All
Age: 18+
Code: NCT06399692
Phase 3, Recruiting
Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
for
Low-Risk, Early Stage Breast Cancer
Location: Glendale CA, Portland OR, Germantown TN
Sponsor: IceCure Medical Ltd.
Sex: All
Age: 70+
Code: NCT07629206
Recruiting
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities
for
Coronary Artery Disease
Location: Glendale CA, Dallas TX, Memphis TN, Nashville TN,
Sponsor: Weill Medical College of Cornell University
Sex: All
Age: 18+
Code: NCT06399705
Phase 3, Recruiting
Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Liquid Molecular Testing Panel in the Community Setting ("DINOSAur II")
for
Stage III Solid Tumors, Stage IV Solid Tumors
Location: Glendale CA
Sponsor: Glendale Adventist Medical Center d/b/a Adventist Health Glendale
Sex: All
Age: 18+
Code: NCT05703243
Recruiting
A Trial to Evaluate the Safety Tolerability and Pharmacokinetics of B1344 by Subcutaneous Injection in Healthy Subjects
for
Nonalcoholic Steatohepatitis
Location: Glendale CA
Sponsor: Tasly Biopharmaceuticals Co., Ltd.
Sex: All
Age: 18 - 55
Code: NCT05655221
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
for
High Risk Cardiovascular Disease, Hypertension,
Location: Glendale CA, Toluca Lake CA, Pasadena CA,
Sponsor: Alnylam Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07181109
Phase 3, Recruiting
New
A Study to Investigate Pharmacokinetics (PK), Safety, and Tolerability of VH4367310 in Healthy Adult Participants
for
HIV Infections
Location: Glendale CA, Baltimore MD
Sponsor: ViiV Healthcare
Sex: All
Age: 18 - 55
Code: NCT07818915
Phase 1, Recruiting
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
for
Major Depressive Disorder
Location: Glendale CA, West Covina CA, Long Beach CA, Anaheim CA,
Sponsor: Autobahn Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06633016
Phase 2, Recruiting
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
for
Colonic Neoplasms, Neoplasms, Colon
Location: Los Angeles CA, Tucson AZ, Grand Island NE, Omaha NE,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT05855200
Phase 3, Recruiting
A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)
for
Neoplasms, Lung
Location: Los Angeles CA, Canton OH, Wilson NC
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07602855
Phase 1, Phase 2, Recruiting
ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer
for
Pancreatic Cancer
Location: Los Angeles CA, San Antonio TX, Plantation FL
Sponsor: Anova Innovation Limited
Sex: All
Age: 18+
Code: NCT07444541
Phase 1, Phase 2, Recruiting
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
for
Solid Tumors
Location: Los Angeles CA, Santa Monica CA, Duarte CA, Orange CA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07522073
Phase 3, Recruiting
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
for
Advanced Solid Tumors, MSI-H or dMMR Advanced Solid Tumors,
Location: Los Angeles CA, Fort Worth TX, Houston TX,
Sponsor: Eikon Therapeutics
Sex: All
Age: 18+
Code: NCT07262619
Phase 1, Phase 2, Recruiting
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
for
Multiple Myeloma
Location: Los Angeles CA, Bullhead City AZ, Fort Worth TX,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT05714839
Phase 1, Phase 2, Recruiting
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
for
Neoplasms, Lung
Location: Los Angeles CA, Fort Worth TX, Hinsdale IL, Canton OH,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07099898
Phase 3, Recruiting
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
for
Refractory Rheumatoid Arthritis (RA),
Location: Los Angeles CA, Covina CA, Los Alamitos CA,
Sponsor: Artiva Biotherapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06991114
Phase 2, Recruiting
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies